Mettl14′ is aberrantly expressed in AML patients (data from Cancer Genome Atlas (TCGA): portal.gdc.cancer.gov/) and several leukaemia cell lines and AML cells carrying t(11q23), t(15;17), or t(8;21) translocation)-mutations [49]. This evidence concerns the gene METTL14 and acute myeloid leukemia.